Latest news with #PerrigoCompanyplc
Yahoo
04-06-2025
- Business
- Yahoo
Perrigo Announces Global Operations and Supply Chain Leadership Transition
Ron Janish, EVP Global Operations and Supply Chain, to Retire Industry Veteran, Matt Winterman, Appointed EVP Product Supply, Operations Strategy & Transformation Officer DUBLIN, June 4, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced the appointment of Matt Winterman as Executive Vice President, Product Supply, Operations Strategy and Transformation Officer, effective June 23, 2025. Mr. Winterman succeeds Ron Janish, who will retire from the Company on September 30, 2025, following a distinguished career at Perrigo spanning more than two decades. Both executives will closely work together to ensure a smooth transition. Throughout his tenure, Mr. Janish played an integral role in advancing and aligning the Company's supply chain with its transformation to a consumer self-care leader and steering its Supply Chain Reinvention program, which significantly reduced portfolio complexity and improved forecast accuracy. His leadership was especially impactful during the COVID-19 pandemic, when Perrigo's global facilities remained operational, ensuring continued supply of essential self-care products to consumers and customers. President and CEO Patrick Lockwood-Taylor commented, "We are deeply grateful to Ron for his more than two decades of outstanding leadership and unwavering commitment to Perrigo. His vision and execution have been instrumental in transforming our global supply chain and ensuring operational resilience, especially during some of the most challenging times in recent history." Mr. Winterman brings more than 20 years of global supply chain and strategy leadership to Perrigo. Most recently, he served as SVP of Global Supply Chain and Strategy at AstraZeneca, overseeing a $54 billion supply chain across 5,000 SKUs. In this capacity, he was instrumental in driving transformation and strategic investment in the manufacturing network. He also served as Global Head of end-to-end Supply Chain at Roche Holding AG, and prior to that in roles of increasing responsibility for technical operations strategy and supply chain performance at GSK plc. Mr. Winterman graduated with a Bachelor of Science degree in Economics from the University of Bristol. Lockwood-Taylor concluded, "We are pleased to welcome Matt to Perrigo and our executive leadership team. His expertise will be pivotal in advancing Perrigo's next-generation manufacturing and supply chain capabilities. Matt's leadership will support the execution of our long-term consumer self-care strategy, ensuring operational excellence across a broad portfolio of molecules, dosage forms and price coverage." "I am honored to join the incredible team at Perrigo," said Mr. Winterman. "I look forward to driving industry-leading initiatives to ensure our supply chain network operates at the highest standards, continuing to consistently and reliably deliver our self-care solutions to consumers and customers every day." About Perrigo Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers. Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill®, Mederma®, Compeed®, EllaOne®, and Solpadeine®. For more information, visit Forward-Looking Statements This press release includes, and the matters discussed in Perrigo's upcoming earnings release will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2024. Perrigo Contact Bradley Joseph, Vice President, Global Investor Relations & Corporate Communications, (269) 686-3373, E-mail: Nicholas Gallagher, Senior Manager, Global Investor Relations & Corporate Communications, (269) 686-3238, E-mail: View original content to download multimedia: SOURCE Perrigo Company plc Sign in to access your portfolio
Yahoo
23-05-2025
- Business
- Yahoo
Perrigo to Attend the Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference
DUBLIN, May 23, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to present at the Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference, being conducted virtually on Tuesday, June 10 at 9 AM ET. Interested parties can access the webcast on the Perrigo website at About Perrigo Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers. Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill®, Mederma®, Compeed®, EllaOne®, and Solpadeine®. For more information, visit Forward-Looking Statements This press release includes, and the matters discussed in Perrigo's presentation at the Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995', as amended. Forward-looking statements relate to future events and involve known and unknown risks, uncertainties and other factors—many of which beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2024. Perrigo Investor Contact Bradley Joseph, Vice President, Global Investor Relations & Corporate Communications; (269) 686-3373; e-mail: Nicholas Gallagher, Senior Manager, Global Investor Relations & Corporate Communications; (269) 686-3238, e-mail: View original content to download multimedia: SOURCE Perrigo Company plc Sign in to access your portfolio
Yahoo
14-05-2025
- Business
- Yahoo
Perrigo Company plc (PRGO): One of the Best Dividend Growth Stocks with High Yields
We recently published a list of the . In this article, we are going to take a look at where Perrigo Company plc (NYSE:PRGO) stands against other best dividend growth stocks. Dividend-paying stocks have been gaining popularity among investors due to their long-term advantages. According to Jeremy Zirin, who leads the US equity team for private clients at UBS Asset Management, companies with a consistent track record of increasing dividends are a smart choice for investors seeking a balanced approach in the current market environment. When markets dipped in April after President Donald Trump announced new tariff policies, investors gravitated toward high-yield dividend stocks. However, as trade tensions began to ease and negotiations progressed, markets recovered. Stocks surged particularly after the US and China agreed to temporarily reduce tariffs. He made the following comment about dividend stocks: 'The higher-dividend-yielding strategies tend to do better when markets are in real turmoil and declining, but if there's more chop, more volatility and potentially upside … you don't want to be overly defensive.' Historically, companies that consistently increase their dividends have tended to be less volatile and often delivered stronger returns than the broader market, including benchmarks like the S&P Equal Weight Index. According to a report by Guggenheim, from May 2005 through December 2024, firms that either initiated or raised their dividends generated an average annual return of 10.5%. In contrast, companies that cut or suspended their payouts posted just 5.5% annually. The overall market returned 10.4% during this timeframe, slightly behind the dividend growers. The report also highlighted that dividend growth strategies have historically performed well in both rising and falling markets, making them an attractive option for investors focused on long-term gains and downside protection. According to a report by S&P Global, the growth of global dividend payments had been slowing since the post-COVID recovery, but that trend reversed last year. In 2024, the growth rate unexpectedly accelerated to 8%, with shareholders receiving approximately $180 billion more than the previous year. This increase came as a surprise given the persistent geopolitical and economic challenges. The report also highlighted that several sectors and regions saw record dividend initiations, including the US technology, media, and telecom (TMT) sector, banks in Italy and Spain, Japan's automotive industry, and a general rise in payouts from Mainland China. Even with extreme price fluctuations, dividend payments from the oil and gas sector remained strong. Looking ahead, the report suggested that this high level of dividends is likely to hold steady, with global payouts expected to remain at $2.3 trillion in 2025. With growing investor appetite for dividend-paying stocks, many companies have responded by gradually increasing their dividend payouts. A report by Janus Henderson revealed that global dividend payments reached a record $1.75 trillion in 2024, reflecting a 6.6% rise on an underlying basis. The overall growth rate came in at 5.2%, slightly held back by a drop in special one-time dividends and the effect of a stronger U.S. dollar. Out of the 49 countries covered in the report, 17—including major economies such as the US, Canada, France, Japan, and China—posted record-high dividend levels. In total, 88% of companies either raised or held their dividends steady over the year. A doctor and a patient discussing the benefits of OTC health and wellness solutions. For this list, we screened for dividend stocks with yields higher than 3% as of May 13. From this group, we further refined our selection criteria by identifying stocks with a dividend growth streak of 10 years or more. The stocks are ranked in ascending order of their dividend yields. At Insider Monkey, we are obsessed with hedge funds. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (). Dividend Yield as of May 13: 4.42% Perrigo Company plc (NYSE:PRGO), headquartered in Ireland, specializes in self-care and over-the-counter health products. Its mission is to support personal wellness by helping consumers take control of managing or preventing common, treatable health issues independently. Since the start of 2025, the stock has surged by nearly 1%. In the first quarter of 2025, Perrigo Company plc (NYSE:PRGO) reported revenue of $1.04 billion, down 3.5% on a YoY basis. The revenue missed analysts' estimates; however, the EPS of $0.60 beat the consensus by $0.03. The company's operating margin rose by 550 basis points to reach 14.0%, mainly due to improved adjusted gross margin and gains from Project Energize. It also updated its fiscal 2025 guidance, now expecting reported net sales to grow between 0% and 3%, compared to the earlier range of 1% to 3%. The forecast for organic net sales growth was adjusted to 1.5% to 4.5%, down from the previous 2.5% to 4.5% range. Perrigo Company plc (NYSE:PRGO) ended the quarter with $410 million in cash and cash equivalents, and its total assets amounted to $9.7 billion. During the quarter, it returned $41 million to shareholders through dividends. Currently, it pays a quarterly dividend of $0.29 per share and has a dividend yield of 4.42%, as of May 13. Due to its strong cash position, the company managed to raise its payouts for 22 consecutive years. Overall, PRGO ranks 11th on our list of the best dividend growth stocks with high yields. While we acknowledge the potential of PRGO as an investment, our conviction lies in the belief that some deeply undervalued dividend stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for a deeply undervalued dividend stock that is more promising than PRGO but that trades at 10 times its earnings and grows its earnings at double digit rates annually, check out our report about the . READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at . Sign in to access your portfolio
Malaysian Reserve
23-04-2025
- Business
- Malaysian Reserve
Perrigo to Release First Quarter 2025 Financial Results on May 7, 2025
DUBLIN, April 23, 2025 /PRNewswire/ — Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its first quarter 2025 financial results on Wednesday, May 7th, 2025, and host a conference call beginning at 8:30 A.M. (EST). The earnings conference call will be available live via webcast to interested parties in the investor relations section of the Perrigo website at or by phone at 800-836-8184, International 646-357-8785, and reference ID # 04449. A taped replay of the call will be available beginning at approximately 12:00 P.M. (EST) Wednesday, May 7, until midnight Wednesday, May 14, 2025. To listen to the replay, dial 888-660-6345, International 646-517-4150, and use access code 04449#. About Perrigo Perrigo Company plc (NYSE: PRGO) is a leading provider of Consumer Self-Care Products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. Visit Perrigo online at Forward-Looking Statements This press release includes, and the matters discussed in Perrigo's upcoming earnings release will include certain 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under 'Risk Factors' in the Company's Form 10-K for the year ended December 31, 2024. Perrigo Contact Bradley Joseph, Vice President, Global Investor Relations & Corporate Communications, (269) 686-3373, E-mail: Nicholas Gallagher, Senior Manager, Global Investor Relations & Corporate Communications, (269) 686-3238, E-mail:
Yahoo
21-04-2025
- Business
- Yahoo
Is Perrigo Co. PLC (PRGO) an Economically Resilient Company?
Heartland Advisors, an investment management company, released its 'Heartland Mid Cap Value Fund' first quarter 2025 investor letter. A copy of the letter can be downloaded here. A growing number of businesses appear to be priced for a significant slowdown in the first quarter, if not a recession, due to the uncertainty surrounding federal policy. The fund returned 0.67% in the quarter compared to a 2.11% fall for the Russell Midcap® Value Index. As risk aversion returned and a focus on downside risk was rewarded, stock selection, which was difficult in a more speculative climate last year, rebounded in the quarter. In addition, you can check the fund's top 5 holdings to determine its best picks for 2025. In its first-quarter 2025 investor letter, Heartland Mid Cap Value Fund highlighted stocks such as Perrigo Company plc (NYSE:PRGO). Perrigo Company plc (NYSE:PRGO) offers over-the-counter health and wellness solutions. The one-month return of Perrigo Company plc (NYSE:PRGO) was -11.13%, and its shares lost 15.43% of their value over the last 52 weeks. On April 17, 2025, Perrigo Company plc (NYSE:PRGO) stock closed at $25.32 per share with a market capitalization of $3.46 billion. Heartland Mid Cap Value Fund stated the following regarding Perrigo Company plc (NYSE:PRGO) in its Q1 2025 investor letter: "Healthcare. While persistent economic concerns may provide a growing list of attractive 'deep value' options in cyclical companies, Perrigo Company plc (NYSE:PRGO) is an example of heavy lifting on 'self-help' bearing fruit in a company that has an economically-resilient demand profile. A doctor and a patient discussing the benefits of OTC health and wellness solutions. Perrigo Company plc (NYSE:PRGO) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 31 hedge fund portfolios held Perrigo Company plc (NYSE:PRGO) at the end of the fourth quarter which was 28 in the previous quarter. While we acknowledge the potential of Perrigo Company plc (NYSE:PRGO) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. In another article, we covered Perrigo Company plc (NYSE:PRGO) and shared the list of best weight loss drugs to buy according to analysts. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: Michael Burry Is Selling These Stocks and A New Dawn Is Coming to US Stocks. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
